We observed that the AMH levels of the non-Hodgkin or Hodgkin lymphoma group were significantly lower in comparison to those in the breast cancer group; on the other side, AFC was found to be not significantly different from those in the other two groups. The gene discussed is AMH; the disease is breast cancer.